Methylation test versus dual staining in the triage of HR-HPV positive women – pilot data from cervical cancer screening
Česká gynekologie · 22.10.2026 · 91 (5) · 357-362
DOI: 10.48095/cccg2026357 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Česká gynekologie, online erschienen am 23.10.2026. Verfasst von M Bartošová und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: DNA Methylation, Uterine Cervical Neoplasms, Papillomavirus Infections, Human Papillomavirus Viruses.
Abstract (Originalsprache)
Introduction
Introduction of high-risk human papillomavirus (HR-HPV) testing into cervical cancer screening increases the detection of high-grade cervical lesions, but also identifies women with transient HR-HPV infections who are at a low risk of progression. To improve risk stratification, biomarkers that can be assessed from the same cervical sample used for HPV testing may be employed, particularly p16/Ki-67 dual-stain cytology and host-cell DNA methylation analysis. Dual staining identifies cells showing HPV-induced transforming activity, but may not fully capture the biological variability of either the host or the HPV infection. Methylation testing reflects epigenetic changes associated with persistent HR-HPV infection and biologically advanced cervical lesions that may therefore provide a more direct indication of the short-term risk of lesion progression.
Objective
To compare performance of p16/Ki-67 dual staining and DNA methylation analysis for risk stratification of HR-HPV-positive women.
Methods
The study included 44 HR-HPV-positive women (median age, 35 years) participating in the Czech cervical cancer screening program who underwent cervical biopsy or conization. Histologically confirmed HSIL/AIS was diagnosed in 52% of cases. Results of both triage methods were evaluated according to age, HPV genotype, and histological findings.
Results
The two methods showed concordant results in approximately 60% of cases, with the highest concordance observed in women older than 35 years. Among women aged 35 years or younger, discordant results were more frequent, most commonly consisting of positive dual staining combined with a negative methylation test. High concordance between the two methods was observed in HPV16-associated lesions, whereas among infections with other HR-HPV genotypes, positive dual staining accompanied by a negative methylation result was more common.
Conclusion
These findings suggest that methylation testing may be particularly useful for the triage of younger HR-HPV-positive women, potentially helping to reduce unnecessary referrals and invasive procedures without compromising the detection of clinically relevant cervical lesions. The findings of this pilot study are currently being validated in a larger prospective study conducted in collaboration with a specialized colposcopy clinic. Key words: cervical cancer screening – HPV testing – DNA methylation – p16/Ki-67 dual staining – triage of HR-HPV-positive women
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
ORCID-Profile: J Bouda, K Černá, N Janovská, J Martínková Němcová
Zitieren
APA
Bartošová, M., Kinkorová Luňáčková, I., Bouda, J., Černá, K., Janovská, N., & Martínková Němcová, J. (2026). Methylation test versus dual staining in the triage of HR-HPV positive women – pilot data from cervical cancer screening. Česká gynekologie, 91(5), 357-362. https://doi.org/10.48095/cccg2026357
Vancouver
Bartošová M, Kinkorová Luňáčková I, Bouda J, Černá K, Janovská N, Martínková Němcová J. Methylation test versus dual staining in the triage of HR-HPV positive women – pilot data from cervical cancer screening. Česká gynekologie. 2026;91(5):357-362. doi:10.48095/cccg2026357
BibTeX
@article{Bartoov2026,
author = {Bartošová, M and Kinkorová Luňáčková, I and Bouda, J and Černá, K and Janovská, N and Martínková Němcová, J},
title = {Methylation test versus dual staining in the triage of HR-HPV positive women – pilot data from cervical cancer screening},
journal = {Česká gynekologie},
year = {2026},
volume = {91},
number = {5},
pages = {357--362},
doi = {10.48095/cccg2026357}
}
EUVIMED